Cargando…

Obesity-Specific Association of Statin Use and Reduced Risk of Recurrence of Early Stage NSCLC

INTRODUCTION: Statins, used for their lipid-lowering activity, have anti-inflammatory and anticancer properties as well. We evaluated this potential benefit of statin use in patients with NSCLC. METHODS: All 613 patients with pathologic stage 1 or 2 NSCLC who had lobectomy without neoadjuvant therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patnaik, Santosh K., Petrucci, Cara, Barbi, Joseph, Seager, Robert J., Pabla, Sarabjot, Yendamuri, Sai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633682/ https://www.ncbi.nlm.nih.gov/pubmed/34877556 http://dx.doi.org/10.1016/j.jtocrr.2021.100254

Ejemplares similares

Visceral Obesity in Non-Small Cell Lung Cancer
por: Nitsche, Lindsay, et al.
Publicado: (2022)

Altered acetyl-CoA metabolism presents a new potential immunotherapy target in the obese lung microenvironment
por: Rosario, Spencer R., et al.
Publicado: (2022)

Tumor Inflammation, Obesity, and Proliferative Status as Biomarkers in Gastroesophageal Adenocarcinoma
por: Mukherjee, Sarbajit, et al.
Publicado: (2021)

Association between visceral obesity, metformin use, and recurrence risk in early-stage colorectal cancer
por: Vedire, Yeshwanth Reddy, et al.
Publicado: (2023)

Overexpression of MicroRNA miR-30a or miR-191 in A549 Lung Cancer or BEAS-2B Normal Lung Cell Lines Does Not Alter Phenotype
por: Patnaik, Santosh Kumar, et al.
Publicado: (2010)

Factors affecting the yield of microRNAs from laser microdissectates of formalin-fixed tissue sections
por: Patnaik, Santosh Kumar, et al.
Publicado: (2012)

MicroRNAs and lung cancer: Biology and applications in diagnosis and prognosis
por: Mallick, Reema, et al.
Publicado: (2010)

Overexpression of the Lung Cancer-Prognostic miR-146b MicroRNAs Has a Minimal and Negative Effect on the Malignant Phenotype of A549 Lung Cancer Cells
por: Patnaik, Santosh Kumar, et al.
Publicado: (2011)

Whole blood microRNA expression may not be useful for screening non-small cell lung cancer
por: Patnaik, Santosh K., et al.
Publicado: (2017)

Quality of Life After Stereotactic Body Radiation Therapy or Surgery for Early-Stage NSCLC: A Systematic Review
por: Iovoli, Austin J., et al.
Publicado: (2022)

MicroRNA Expression Profiles of Whole Blood in Lung Adenocarcinoma
por: Patnaik, Santosh K., et al.
Publicado: (2012)

Expression of MicroRNAs in the NCI-60 Cancer Cell-Lines
por: Patnaik, Santosh K., et al.
Publicado: (2012)

Obesity and lung cancer—a narrative review
por: Vedire, Yeshwanth, et al.
Publicado: (2023)

Statins and immunotherapy: Togetherness makes strength The potential effect of statins on immunotherapy for NSCLC
por: Rossi, Alessandro, et al.
Publicado: (2021)

Sublethal Radiation Affects Antigen Processing and Presentation Genes to Enhance Immunogenicity of Cancer Cells
por: Punnanitinont, Achamaporn, et al.
Publicado: (2020)

Survival Benefit of Perioperative Systemic Chemotherapy for Patients With N0 to N1 NSCLC Having Synchronous Brain Metastasis
por: Vedire, Yeshwanth R., et al.
Publicado: (2023)

Statin drugs to reduce breast cancer recurrence and mortality
por: Beckwitt, Colin H., et al.
Publicado: (2018)

Aging augments obesity-induced thymic involution and peripheral T cell exhaustion altering the “obesity paradox”
por: Vick, Logan V., et al.
Publicado: (2023)

Risk factors of postoperative recurrences in patients with clinical stage I NSCLC
por: Chen, Ying-Yi, et al.
Publicado: (2014)

Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC)
por: Dahlgaard, Jesper, et al.
Publicado: (2011)

Skeletal muscle index is associated with long term outcomes after lobectomy for non-small cell lung cancer
por: Vedire, Yeshwanth, et al.
Publicado: (2023)

Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC
por: Lee, Jay M., et al.
Publicado: (2023)

Immunoprofiling bronchoalveolar lavage cells reveals multifaceted smoking-associated immune dysfunction
por: Smith, Randall, et al.
Publicado: (2023)

Stage and tissue-specific prognostic impact of miR-182 in NSCLC
por: Stenvold, Helge, et al.
Publicado: (2014)

Commentary: Expeditious treatment of pericardial herniation after blunt trauma
por: Jordan, Sean, et al.
Publicado: (2020)

Statins and risk of breast cancer recurrence
por: Sakellakis, Minas, et al.
Publicado: (2016)

Advances in lung cancer surgery
por: Hennon, Mark W., et al.
Publicado: (2012)

The Role of Lymphadenectomy in Early-Stage NSCLC
por: Manfredini, Beatrice, et al.
Publicado: (2023)

Long-Term Recurrence of Completely Resected NSCLC
por: Masago, Katsuhiro, et al.
Publicado: (2020)

Exploring the Impact of the Obesity Paradox on Lung Cancer and Other Malignancies
por: Nitsche, Lindsay Joyce, et al.
Publicado: (2022)

APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC
por: Li, Yanping, et al.
Publicado: (2021)

Immunotherapy for Stage III NSCLC: Durvalumab and Beyond
por: Fitzpatrick, Orla, et al.
Publicado: (2021)

Impact of statin use on cancer-specific mortality and recurrence: A meta-analysis of 60 observational studies
por: Yang, Jing, et al.
Publicado: (2020)

Treatment patterns and survival of patients with locoregional recurrence in early-stage NSCLC: a literature review of real-world evidence
por: Bowes, Kathleen, et al.
Publicado: (2022)

Staging of non-small cell lung cancer (NSCLC)
por: Rankin, S C
Publicado: (2006)

Targeted Therapies in Early Stage NSCLC: Hype or Hope?
por: Friedlaender, Alex, et al.
Publicado: (2020)

The current treatment landscape in the UK for stage III NSCLC
por: Evison, Matthew
Publicado: (2020)

Management of Typical and Atypical Pulmonary Carcinoids Based on Different Established Guidelines
por: Gosain, Rohit, et al.
Publicado: (2018)

A Clinical Evaluation of Statin Pleiotropy: Statins Selectively and Dose-Dependently Reduce Vascular Inflammation
por: van der Meij, Evelien, et al.
Publicado: (2013)

Obesity Is Associated With Progression of Atherosclerosis During Statin Treatment
por: Sandfort, Veit, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_90p48f5t3knh7qone6t5kfdccv